0001415889-24-000276.txt : 20240103
0001415889-24-000276.hdr.sgml : 20240103
20240103161518
ACCESSION NUMBER: 0001415889-24-000276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Russo Rene
CENTRAL INDEX KEY: 0001722066
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 24506551
MAIL ADDRESS:
STREET 1: C/O ARSANIS, INC.
STREET 2: 890 WINTER STREET, SUITE 230
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-01032024_040101.xml
X0508
4
2024-01-01
0001840233
Xilio Therapeutics, Inc.
XLO
0001722066
Russo Rene
828 WINTER STREET
SUITE 300
WALTHAM
MA
02451
true
true
false
false
PRESIDENT AND CEO
0
Restricted Stock Units
2024-01-01
4
A
0
177000
0
A
Common Stock
177000
177000
D
Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.
/s/ Christopher Frankenfield, Attorney-in-Fact
2024-01-03